This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
PharmaceuticalPharmaceutical companies have had a difficult year: the industry is grappling with softening demand for COVID-19-related products. And many small to midsize pharmaceuticals are still looking for funding and partnerships to move their products forward in clinical trials.
Neighborhood and Built Environment: Housing quality, transportation access, availability of nutritious foods, pollution levels, and neighborhood crime. This does not even account for medical and pharmaceutical costs. Education Access and Quality: Education level achieved, literacy, childhood development and education.
Rethinking the Workplace By the 2040s, almost all data will be digitized—which means AI will have access to it all for decision-making and optimization. Pharmaceutical companies will find their R&D costs cut significantly, simply because AI can help invent many drugs at much lower costs, including cures for rare diseases.
When Covid came along, Cantu and his team empowered their clients to find employment, transportation, childcare and housing. This organization provided transportation for children from their schools to the center. has centered his career around educating and coaching people to make better decisions. James Langabeer, Ph.D.,
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content